Efficacy of bile acid profiles in diagnosing and staging of alcoholic liver disease

References

• Byass P. The global burden of liver disease: a challenge for methods and for public health. BMC Med. 2014;12:159.
   PubMed Web of Science ®Google Scholar
• Xiao J, Wang F, Wong NK, et al. Global liver disease burdens and research trends: analysis from a Chinese perspective. J Hepatol. 2019;71(1):212–221.
   PubMed Web of Science ®Google Scholar
• Yang YM, Cho YE, Hwang S. Crosstalk between oxidative stress and inflammatory liver injury in the pathogenesis of alcoholic liver disease. IJMS. 2022;23(2):774.
   Web of Science ®Google Scholar
• Tripathi A, Debelius J, Brenner DA, et al. The gut-liver axis and the intersection with the microbiome. Nat Rev Gastroenterol Hepatol. 2018;15(7):397–411.
   PubMed Web of Science ®Google Scholar
• Li T, Chiang JYL. Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease. Hepatobiliary Surg Nutr. 2020;9(2):152–169.
   PubMed Web of Science ®Google Scholar
• Shah ND, Ventura-Cots M, Abraldes JG, et al. Alcohol-related liver disease is rarely detected at early stages compared with liver diseases of other etiologies worldwide. Clin Gastroenterol Hepatol. 2019;17(11):2320–2329.e12.
   PubMed Web of Science ®Google Scholar
• Fuster D, Samet JH. Alcohol use in patients with chronic liver disease. N Engl J Med. 2018;379(13):1251–1261.
   PubMed Web of Science ®Google Scholar
• Singal AK, Bataller R, Ahn J, et al. ACG clinical guideline: alcoholic liver disease. Am J Gastroenterol. 2018;113(2):175–194.
   PubMed Web of Science ®Google Scholar
• Kong LZ, Chandimali N, Han YH, et al. Pathogenesis, early diagnosis, and therapeutic management of alcoholic liver disease. IJMS. 2019;20(11):2712.
   Web of Science ®Google Scholar
• European Association for Study of Liver; Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH clinical practice guidelines: non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63:237–264.
   PubMed Web of Science ®Google Scholar
• Rinschen MM, Ivanisevic J, Giera M, et al. Identification of bioactive metabolites using activity metabolomics. Nat Rev Mol Cell Biol. 2019;20(6):353–367.
   PubMed Web of Science ®Google Scholar
• Bujak R, Struck-Lewicka W, Markuszewski MJ, et al. Metabolomics for laboratory diagnostics. J Pharm Biomed Anal. 2015;113:108–120.
   PubMed Web of Science ®Google Scholar
• Voutilainen T, Karkkainen O. Changes in the human metabolome associated with alcohol use: a review. Alcohol Alcohol. 2019;54(3):225–234.
   PubMed Web of Science ®Google Scholar
• Gao B, Zhu Y, Gao N, et al. Integrative analysis of metabolome and microbiome in patients with progressive alcohol-associated liver disease. Metabolites. 2021;11(11):766.
   PubMed Web of Science ®Google Scholar
• Loftfield E, Stepien M, Viallon V, et al. Novel biomarkers of habitual alcohol intake and associations with risk of pancreatic and liver cancers and liver disease mortality. J Natl Cancer Inst. 2021;113(11):1542–1550.
   PubMedGoogle Scholar
• Chinese Foundation for Hepatitis Prevention and Control; Chinese Society of Infectious Disease and Chinese Society of Hepatology, Chinese Medical Association, et al. Consensus on clinical application of transient elastography detecting liver fibrosis: a 2018 update. Zhonghua Gan Zang Bing Za Zhi. 2019;27:182–191.
   PubMedGoogle Scholar
• Guijas C, Montenegro-Burke JR, Domingo-Almenara X, et al. METLIN: a technology platform for identifying knowns and unknowns. Anal. Chem. 2018;90(5):3156–3164.
   PubMed Web of Science ®Google Scholar
• Jia R, Chen Q, Zhou Q, et al. Characteristics of serum metabolites in sporadic amyotrophic lateral sclerosis patients based on gas chromatography-mass spectrometry. Sci Rep. 2021;11(1):20786.
   PubMed Web of Science ®Google Scholar
• Johnson CH, Ivanisevic J, Siuzdak G. Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol. 2016;17(7):451–459.
   PubMed Web of Science ®Google Scholar
• Xie G, Zhong W, Li H, et al. Alteration of bile acid metabolism in the rat induced by chronic ethanol consumption. FASEB J. 2013;27(9):3583–3593.
   PubMed Web of Science ®Google Scholar
• Stroeve JH, Brufau G, Stellaard F, et al. Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice. Lab Invest. 2010;90(10):1457–1467.
   PubMed Web of Science ®Google Scholar
• Ticho AL, Malhotra P, Dudeja PK, et al. Intestinal absorption of bile acids in health and disease. Compr Physiol. 2019;10(1):21–56.
   PubMed Web of Science ®Google Scholar
• Wu W, Zhu B, Peng X, et al. Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease. Biochem Biophys Res Commun. 2014;443(1):68–73.
   PubMed Web of Science ®Google Scholar
• Chanda D, Kim YH, Li T, et al. Hepatic cannabinoid receptor type 1 mediates alcohol-induced regulation of bile acid enzyme genes expression via CREBH. PLoS One. 2013;8(7):e68845.
   PubMed Web of Science ®Google Scholar
• Miura T, Tachikawa M, Ohtsuka H, et al. Application of quantitative targeted absolute proteomics to profile protein expression changes of hepatic transporters and metabolizing enzymes during cholic acid-promoted liver regeneration. J Pharm Sci. 2017;106(9):2499–2508.
   PubMed Web of Science ®Google Scholar
• Kakiyama G, Pandak WM, Gillevet PM, et al. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis. J Hepatol. 2013;58(5):949–955.
   PubMed Web of Science ®Google Scholar
• Ridlon JM, Harris SC, Bhowmik S, et al. Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes. 2016;7(1):22–39.
   PubMed Web of Science ®Google Scholar
• Bajaj JS. Alcohol, liver disease and the gut microbiota. Nat Rev Gastroenterol Hepatol. 2019;16(4):235–246.
   PubMed Web of Science ®Google Scholar
• Gong X, Zhang Q, Ruan Y, et al. Chronic alcohol consumption increased bile acid levels in enterohepatic circulation and reduced efficacy of irinotecan. Alcohol Alcohol. 2020;55(3):264–277.
   PubMed Web of Science ®Google Scholar
• Ciocan D, Spatz M, Trainel N, et al. Modulation of the bile acid enterohepatic cycle by intestinal microbiota alleviates alcohol liver disease. Cells. 2022;11(6):968.
   PubMed Web of Science ®Google Scholar
• Sang C, Wang X, Zhou K, et al. Bile acid profiles are distinct among patients with different etiologies of chronic liver disease. J Proteome Res. 2021;20(5):2340–2351.
   PubMed Web of Science ®Google Scholar
• Talwalkar JA, Kurtz DM, Schoenleber SJ, et al. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2007;5(10):1214–1220.
   PubMed Web of Science ®Google Scholar